deltatrials
Terminated PHASE4 INTERVENTIONAL 2-arm NCT05312970

Varithena Versus Endothermal Ablation of the Great Saphenous Vein (VERITAS) (VERITAS)

A Phase 4 Randomized Trial Comparing Varithena to Endothermal Ablation for the Treatment of the Great Saphenous Vein

Sponsor: Boston Scientific Corporation

Conditions Varicose Veins
Interventions FDA-approved Endothermal Ablation (ETA) systems Varithena®
Updated 28 times since 2022 Last updated: Sep 23, 2024 Started: Feb 10, 2023 Primary completion: Apr 4, 2024 Completion: Apr 4, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Enrollment challenges and a difficult insurance coverage landscape

Other terminated trials from Boston Scientific Corporation

More terminations from Boston Scientific Corporation

Other Varicose Veins trials with similar outcome

Browse all Varicose Veins trials

This PHASE4 trial investigates Varicose Veins and is currently terminated or withdrawn. Boston Scientific Corporation leads this study, which shows 28 recorded versions since 2023 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~May 2022 – ~Jul 2022 · 2 months · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Dec 2022 · 30 days · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Feb 2023 · 31 days · monthly snapshot~Feb 2023 – ~Mar 2023 · 28 days · monthly snapshot~Mar 2023 – ~Apr 2023 · 31 days · monthly snapshot~Apr 2023 – ~May 2023 · 30 days · monthly snapshot~May 2023 – ~Jun 2023 · 31 days · monthly snapshot~Jun 2023 – ~Jul 2023 · 30 days · monthly snapshot~Jul 2023 – ~Aug 2023 · 31 days · monthly snapshot~Aug 2023 – ~Sep 2023 · 31 days · monthly snapshot~Sep 2023 – ~Oct 2023 · 30 days · monthly snapshot~Oct 2023 – ~Nov 2023 · 31 days · monthly snapshot~Nov 2023 – ~Dec 2023 · 30 days · monthly snapshot~Dec 2023 – ~Jan 2024 · 31 days · monthly snapshot~Jan 2024 – ~Feb 2024 · 31 days · monthly snapshot~Feb 2024 – ~Mar 2024 · 29 days · monthly snapshot~Mar 2024 – ~Apr 2024 · 31 days · monthly snapshot~Apr 2024 – ~May 2024 · 30 days · monthly snapshot~May 2024 – ~Jun 2024 · 31 days · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Sep 2025 · 11 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

28 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE4

  2. Oct 2024 — Sep 2025 [monthly]

    Terminated PHASE4

  3. Sep 2024 — Oct 2024 [monthly]

    Terminated PHASE4

  4. Aug 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  5. Jul 2024 — Aug 2024 [monthly]

    Terminated PHASE4

▶ Show 23 earlier versions

  1. Jun 2024 — Jul 2024 [monthly]

    Terminated PHASE4

    Status: Active Not Recruiting → Terminated

  2. May 2024 — Jun 2024 [monthly]

    Active Not Recruiting PHASE4

    Status: Recruiting → Active Not Recruiting

  3. Apr 2024 — May 2024 [monthly]

    Recruiting PHASE4

  4. Mar 2024 — Apr 2024 [monthly]

    Recruiting PHASE4

  5. Feb 2024 — Mar 2024 [monthly]

    Recruiting PHASE4

  6. Jan 2024 — Feb 2024 [monthly]

    Recruiting PHASE4

  7. Dec 2023 — Jan 2024 [monthly]

    Recruiting PHASE4

  8. Nov 2023 — Dec 2023 [monthly]

    Recruiting PHASE4

  9. Oct 2023 — Nov 2023 [monthly]

    Recruiting PHASE4

  10. Sep 2023 — Oct 2023 [monthly]

    Recruiting PHASE4

  11. Aug 2023 — Sep 2023 [monthly]

    Recruiting PHASE4

  12. Jul 2023 — Aug 2023 [monthly]

    Recruiting PHASE4

  13. Jun 2023 — Jul 2023 [monthly]

    Recruiting PHASE4

  14. May 2023 — Jun 2023 [monthly]

    Recruiting PHASE4

  15. Apr 2023 — May 2023 [monthly]

    Recruiting PHASE4

  16. Mar 2023 — Apr 2023 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  17. Feb 2023 — Mar 2023 [monthly]

    Not Yet Recruiting PHASE4

  18. Jan 2023 — Feb 2023 [monthly]

    Not Yet Recruiting PHASE4

  19. Dec 2022 — Jan 2023 [monthly]

    Not Yet Recruiting PHASE4

  20. Nov 2022 — Dec 2022 [monthly]

    Not Yet Recruiting PHASE4

  21. Sep 2022 — Nov 2022 [monthly]

    Not Yet Recruiting PHASE4

  22. Jul 2022 — Sep 2022 [monthly]

    Not Yet Recruiting PHASE4

  23. May 2022 — Jul 2022 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Boston Scientific Corporation
Data source: Boston Scientific Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations